Literature DB >> 23918153

Single nucleotide polymorphisms of caudal type homeobox 1 and 2 are associated with Barrett's esophagus.

Dongren Ren1, Gaolin Zheng, Susan Bream, Whitney Tevebaugh, Nicholas J Shaheen, Xiaoxin Chen.   

Abstract

BACKGROUND: Barrett's esophagus (BE), the premalignant lesion of esophageal adenocarcinoma, is believed to develop as a result of chronic gastroesophageal reflux disease (GERD). Approximately 10 % of subjects with GERD progress to BE. Genetic, epigenetic and other risk factors may contribute to this inter-individual variability. Caudal type homeobox 1 (Cdx1) and Caudal type homeobox 2 (Cdx2) play important regulatory roles in the development of human BE. AIMS: To determine associations between Cdx1 and Cdx2 single nucleotide polymorphisms (SNPs) and BE.
METHODS: Genomic DNA was extracted from blood samples collected from BE (n = 109) and GERD (n = 223) patients for genotyping of 5 SNPs each of Cdx1 and Cdx2 using TaqMan allelic discrimination assays. Odds ratios and 95 % confidence intervals of SNPs and haplotypes were calculated with a logistic regression model adjusted for factors including age, sex and hiatal hernia. Interactions between genetic variants and these three risk factors were also analyzed.
RESULTS: Older age (≥50 years), male sex and hiatal hernia were significantly associated with BE (P < 0.001). Five variants of Cdx1 SNPs (rs3776082, rs717746 and rs3776083), one Cdx1 haplotype, and three variants of Cdx2 SNPs (rs4769585 and rs3812863) were associated with BE (P < 0.05). Statistically significant interactions were detected between most of these SNPs and the three risk factors (P < 0.05).
CONCLUSION: Certain SNPs of Cdx1 and Cdx2 and their interactions with other risk factors are associated with BE, and may contribute to human susceptibility to BE.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23918153      PMCID: PMC3947210          DOI: 10.1007/s10620-013-2804-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia.

Authors:  Akashi Eda; Hiroyuki Osawa; Ichiro Yanaka; Kiichi Satoh; Hiroyuki Mutoh; Ken Kihira; Kentaro Sugano
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

Review 2.  Definition and clinical importance of haplotypes.

Authors:  Dana C Crawford; Deborah A Nickerson
Journal:  Annu Rev Med       Date:  2005       Impact factor: 13.739

3.  CDX1 is an important molecular mediator of Barrett's metaplasia.

Authors:  N A C S Wong; J Wilding; S Bartlett; Y Liu; B F Warren; J Piris; N Maynard; R Marshall; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-13       Impact factor: 11.205

4.  Barrett esophagus in sexagenarian identical twins.

Authors:  M D Gelfand
Journal:  J Clin Gastroenterol       Date:  1983-06       Impact factor: 3.062

5.  Hiatal hernia and acid reflux frequency predict presence and length of Barrett's esophagus.

Authors:  Benjamin Avidan; Amnon Sonnenberg; Thomas G Schnell; Stephen J Sontag
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

6.  The homeodomain protein CDX2 is an early marker of Barrett's oesophagus.

Authors:  L M G Moons; D A Bax; E J Kuipers; H Van Dekken; J Haringsma; A H M Van Vliet; P D Siersema; J G Kusters
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

7.  Silencing of CDX2 expression in colon cancer via a dominant repression pathway.

Authors:  Takao Hinoi; Massimo Loda; Eric R Fearon
Journal:  J Biol Chem       Date:  2003-08-28       Impact factor: 5.157

8.  Putative intestine-specific enhancers located in 5' sequence of the CDX1 gene regulate CDX1 expression in the intestine.

Authors:  Erinn B Rankin; Wei Xu; Debra G Silberg; EunRan Suh
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-01-08       Impact factor: 4.052

9.  Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice.

Authors:  H Mutoh; S Sakurai; K Satoh; H Osawa; Y Hakamata; T Takeuchi; K Sugano
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

10.  Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia.

Authors:  Gabriel M Groisman; Mary Amar; Alona Meir
Journal:  Mod Pathol       Date:  2004-10       Impact factor: 7.842

View more
  5 in total

1.  Are caudal-type homeobox genes causal for gastro-esophageal reflux disease and Barrett's esophagus?

Authors:  Silke Laßmann; Martin Werner
Journal:  Dig Dis Sci       Date:  2014-01       Impact factor: 3.199

Review 2.  Genetic susceptibility to Barrett's oesophagus: Lessons from early studies.

Authors:  John M Findlay; Mark R Middleton; Ian Tomlinson
Journal:  United European Gastroenterol J       Date:  2015-10-13       Impact factor: 4.623

3.  Intrinsic Cellular Susceptibility to Barrett's Esophagus in Adults Born with Esophageal Atresia.

Authors:  Chantal A Ten Kate; Annelies de Klein; Bianca M de Graaf; Michail Doukas; Antti Koivusalo; Mikko P Pakarinen; Robert van der Helm; Tom Brands; Hanneke IJsselstijn; Yolande van Bever; René M H Wijnen; Manon C W Spaander; Erwin Brosens
Journal:  Cancers (Basel)       Date:  2022-01-20       Impact factor: 6.639

Review 4.  Genetic Biomarkers of Barrett's Esophagus Susceptibility and Progression to Dysplasia and Cancer: A Systematic Review and Meta-Analysis.

Authors:  John M Findlay; Mark R Middleton; Ian Tomlinson
Journal:  Dig Dis Sci       Date:  2015-10-07       Impact factor: 3.199

5.  Role of enterocyte-specific gene polymorphisms in response to adjuvant treatment for stage III colorectal cancer.

Authors:  Mitsukuni Suenaga; Shu Cao; Wu Zhang; Satoshi Matsusaka; Satoshi Okazaki; Martin D Berger; Yuji Miyamoto; Marta Schirripa; Afsaneh Barzi; Noriko Yamamoto; Toshiharu Yamaguchi; Heinz-Josef Lenz
Journal:  Pharmacogenet Genomics       Date:  2021-01       Impact factor: 2.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.